Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

被引：7
|
作者：
Bassler, Dirk [1 ]
van den Anker, John [2 ,3 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauenklin Str 10, CH-8091 Zurich, Switzerland
[2] Univ Basel, Div Paediat Pharmacol & Pharmacometr, Childrens Hosp, Spitalstr 33, CH-4056 Basel, Switzerland
[3] Childrens Natl Med Ctr, Div Clin Pharmacol, 111 Michigan Ave NorthWest, Washington, DC 20010 USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 06期
关键词：
Bronchopulmonary dysplasia; Inhaled corticosteroids; Inhaled bronchodilators; Systemic corticosteroids; Dexamethasone; Hydrocortisone; Pharmacology; CHRONIC LUNG-DISEASE; LOW-DOSE HYDROCORTISONE; PRETERM INFANTS; PREMATURE-INFANTS; RANDOMIZED-TRIAL; CEREBRAL-PALSY; DOUBLE-BLIND; PREVENTION; THERAPY; PHARMACOKINETICS;
D O I：
10.1016/j.pcl.2017.08.012
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
All definitions of bronchopulmonary dysplasia (BPD) have limitations, and a new definition for the purpose of clinical research, benchmarking, and prognostic prediction is needed. Different inhaled and systemic drugs are currently used to prevent or treat BPD. Despite some positive effects on BPD, more information about the effects of inhaled corticosteroids is required to assess overall efficacy and associated risks. One needs to balance the risks of neurodevelopmental impairment owing to systemic corticosteroids against those of BPD itself. Future studies should, therefore, focus on infants with a very high risk of developing BPD and include pharmacokinetics and long-term developmental outcomes.
引用
收藏
页码：1355 / +
页数：14
相关论文
共 50 条
  • [1] Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants
    Lemyre, Brigitte
    Dunn, Michael
    Thebaud, Bernard
    PAEDIATRICS & CHILD HEALTH, 2020, 25 (05) : 322 - 326
  • [2] Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
    Doyle, Lex W.
    NEONATOLOGY, 2021, 118 (02) : 244 - 251
  • [3] Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
    Bulbul, Ali
    Bacak, Tolga
    Avsar, Hasan
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (02): : 171 - 181
  • [4] Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis
    Shinwell, Eric S.
    Portnov, Igor
    Meerpohl, Joerg J.
    Karen, Tanja
    Bassler, Dirk
    PEDIATRICS, 2016, 138 (06)
  • [5] Postnatal administration of corticosteroids to prevent or treat bronchopulmonary dysplasia in premature newborns
    Lemyre, Brigitte
    Dunn, Michael
    Thebaud, Bernard
    PAEDIATRICS & CHILD HEALTH, 2020, 25 (05) : 327 - 331
  • [6] Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids
    Szabo, Hajnalka
    Baraldi, Eugenio
    Colin, Andrew A.
    PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 600 - 608
  • [7] Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle, Lex W.
    Cheong, Jeanie L. Y.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2017, 22 (05) : 290 - 295
  • [8] Reviewing the use of corticosteroids in bronchopulmonary dysplasia
    de Oliveira Peixoto, Fernanda Aparecida
    Sucasas Costa, Paulo Sergio
    JORNAL DE PEDIATRIA, 2016, 92 (02) : 122 - 128
  • [9] Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
    Slaughter, Jonathan L.
    Stenger, Michael R.
    Reagan, Patricia B.
    Jadcherla, Sudarshan R.
    PLOS ONE, 2014, 9 (09):
  • [10] Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants
    Slaughter, Jonathan L.
    Klebanoff, Mark A.
    Hade, Erinn M.
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2024, 38 (06) : 495 - 504
12345